The anterior saphenous vein. Part 4. Clinical and technical considerations in treatment. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of Phlebology.

Phlebology Pub Date : 2024-06-01 Epub Date: 2023-12-21 DOI:10.1177/02683555231223063

Edward M Boyle, Rachel Drgastin, Nicos Labropoulos, Alberto Caggiati, Antonios Gasparis, Suat Doganci, Mark Meissner

{"title":"The anterior saphenous vein. Part 4. Clinical and technical considerations in treatment. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of Phlebology.","authors":"Edward M Boyle, Rachel Drgastin, Nicos Labropoulos, Alberto Caggiati, Antonios Gasparis, Suat Doganci, Mark Meissner","doi":"10.1177/02683555231223063","DOIUrl":null,"url":null,"abstract":"Background: The decision to treat a refluxing anterior saphenous vein (ASV) should be a clinical decision based on the assessment on the ASV's contribution to patient's signs and symptoms. Once the decision to treat has been made, there are anatomic, clinical, and technical considerations in treatment planning.Methods: Clinical scenarios were discussed by a panel of experts and common anatomic, clinical, and technical considerations were identified.Results: There are unique clinical considerations such as whether both the great saphenous vein (GSV) and ASV should be concomitantly treated, if a normal ASV should be treated when treating a refluxing GSV and when and how to treat the associated tributary varicose tributaries. Being aware of the anatomic, clinical, and technical considerations allows development of a treatment plan that optimizes long-term outcomes in patients with ASV reflux.Conclusion: Ultimately the treatment plan should be tailored to address these types of variables in a patient-centered discussion.","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"333-341"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129528/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phlebology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/02683555231223063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The decision to treat a refluxing anterior saphenous vein (ASV) should be a clinical decision based on the assessment on the ASV's contribution to patient's signs and symptoms. Once the decision to treat has been made, there are anatomic, clinical, and technical considerations in treatment planning.

Methods: Clinical scenarios were discussed by a panel of experts and common anatomic, clinical, and technical considerations were identified.

Results: There are unique clinical considerations such as whether both the great saphenous vein (GSV) and ASV should be concomitantly treated, if a normal ASV should be treated when treating a refluxing GSV and when and how to treat the associated tributary varicose tributaries. Being aware of the anatomic, clinical, and technical considerations allows development of a treatment plan that optimizes long-term outcomes in patients with ASV reflux.

Conclusion: Ultimately the treatment plan should be tailored to address these types of variables in a patient-centered discussion.

查看原文本刊更多论文

隐静脉前端。第 4 部分。治疗中的临床和技术考虑因素。由美国静脉和淋巴协会、美国静脉论坛和国际静脉学联盟认可。

背景：治疗反流隐前静脉（ASV）的决定应根据对ASV对患者体征和症状影响的评估做出临床决定。一旦决定进行治疗，在制定治疗计划时就需要考虑解剖、临床和技术因素：方法：由专家小组讨论临床情景，并确定常见的解剖、临床和技术考虑因素：结果：有一些独特的临床考虑因素，如是否应该同时治疗大隐静脉（GSV）和ASV，在治疗反流的GSV时是否应该治疗正常的ASV，以及何时和如何治疗相关的曲张支流。了解了解剖、临床和技术方面的考虑因素，就可以制定治疗方案，优化 ASV 回流患者的长期疗效：最终，治疗方案应在以患者为中心的讨论中针对这些变量进行调整。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Phlebology

自引率

0.00%

发文量